Jonathan Almaden
Impact in
-
- NF-κB Signaling Pathways
-
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Papers in
-
- NF-κB Signaling Pathways 4
-
- Immune Response and Inflammation 4
- Co-authors
- Alexander Hoffmann (4 shared papers)Jeremy Davis‐Turak (4 shared papers)Maxim Nikolaievich Shokhirev (3 shared papers)Shaoxian Sun (2 shared papers)Rachel Tsui (2 shared papers)Dennis C. Otero (2 shared papers)Erik C. Ralph (1 shared paper)J. D. Thomson (1 shared paper)
- Journals
- Cell Reports (1 paper)Cancer Cell (1 paper)Metabolic Engineering (1 paper)The Journal of Immunology (1 paper)Molecular Systems Biology (1 paper)
- Partner nations
- United StatesFranceIndia
In The Last Decade
Jonathan Almaden
7 papers receiving 352 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 96
- Immunology 110
- Oncology 105
- Genetics 40
- Pulmonary and Respiratory Medicine 84
Countries citing papers authored by Jonathan Almaden
This map shows the geographic impact of Jonathan Almaden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Almaden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Almaden more than expected).
Fields of papers citing papers by Jonathan Almaden
This network shows the impact of papers produced by Jonathan Almaden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Almaden. The network helps show where Jonathan Almaden may publish in the future.
Co-authors
The 21 scholars most cited alongside Jonathan Almaden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 140 | |
| 2 | 2014 | 60 | |
| 3 | 2016 | 42 | |
| 4 | 2014 | 41 | |
| 5 | 2008 | 30 | |
| 6 | 2015 | 27 | |
| 7 | 2005 | 16 |
About Jonathan Almaden
Jonathan Almaden is a scholar working on Cancer Research, Immunology, Oncology, Genetics and Pharmacology, having authored 7 papers that have together received 356 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (4 papers), Immune Response and Inflammation (4 papers), Pancreatic function and diabetes (1 paper), Lung Cancer Research Studies (1 paper), Advanced Breast Cancer Therapies (1 paper), Peroxisome Proliferator-Activated Receptors (1 paper), Melanoma and MAPK Pathways (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Cancer Research (96 citations), Immunology (110 citations), Oncology (105 citations), Genetics (40 citations) and Pulmonary and Respiratory Medicine (84 citations). Jonathan Almaden has collaborated with scholars based in United States, France and India. Frequent co-authors include Alexander Hoffmann, Jeremy Davis‐Turak, Maxim Nikolaievich Shokhirev, Shaoxian Sun, Rachel Tsui, Dennis C. Otero, Erik C. Ralph, J. D. Thomson, Julia V. Ponomarenko and Jessica Fujimoto. Their work appears in journals such as Cell Reports, Cancer Cell, Metabolic Engineering, The Journal of Immunology and Molecular Systems Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.